Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function

NCT02678000 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease (CKD)

Interventions

DRUG: LHW090
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals